title: Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease.
abstract: Neurofibrillary tangles (NFT) in Alzheimer's disease (AD) are composed of abnormally phosphorylated tau proteins. Many phosphorylation sites have been reported in the AD brain, and NFT distribution was now roughly classified into 3 stages by Braak stage; this classification is based on pathological studies using the specific silver impregnation technique. The aim of our study was to examine the regional distribution of differently phosphorylated tau proteins with 5 site-specific monoclonal antibodies against the tau proteins, AT8, AT180, HT7, Tau2 and Tau5. We then compared our findings with those obtained from silver-stained NFT in an attempt to clarify the relationship between abnormal phosphorylation sites of the tau protein and NFT development. AT180 and AT8 labeled the highest and Tau2 the lowest density of NFT in any regions, while Tau5 and HT7 showed inconsistent distribution. In the limbic cortex, cornu ammonis, entorhinal cortex and cingulate cortex, silver-stained NFT density significantly correlated with density of NFT labeled with the 5 anti-tau antibodies, but cerebral isocortices showed heterogenous patterns of tau-positive NFT. Quantification of tau-positive regional NFT density showed that the AD-associated phosphorylation process progresses from the C-terminal to the N-terminal of the amino acid sequence, and correlation of Gallyas-stained NFT density with tau-labeled NFT density was more significant in the limbic cortices than the cerebral isocortices, which implies that stereotypical phosphorylation occurs in the limbic structures.
authors.affiliation: Department of Psychiatry and Neurobiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan. hirozou@p2223.nsk.ne.jp
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nakano
authors.forename: Katsuji
authors.initials: K
authors.lastname: Kobayashi
authors.forename: Kaoru
authors.initials: K
authors.lastname: Sugimori
authors.forename: Masao
authors.initials: M
authors.lastname: Shimazaki
authors.forename: Kenji
authors.initials: K
authors.lastname: Miyazu
authors.forename: Masahiro
authors.initials: M
authors.lastname: Hayashi
authors.forename: Hisakazu
authors.initials: H
authors.lastname: Furuta
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D000911:Antibodies, Monoclonal; D001923:Brain Chemistry / Q000502:physiology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D016874:Neurofibrillary Tangles / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000737:chemistry; D010766:Phosphorylation; D016622:Silver Staining; D016875:tau Proteins / Q000032:analysis*
chemical_list: D000911:Antibodies, Monoclonal; D016875:tau Proteins